Across Europe, around 500 million working days are lost each year due to chronic and acute pain, resulting in a huge social and economic impact. Among the different remedies available for the symptomatic treatment of pain, non-steroidal anti-inflammatory drugs (NSAIDs) have been, and still are, widely used. In the area of pain and inflammation, IBSA offers various types of products for topical, oral and transdermal use.
